The role of EMT and MET in cancer dissemination
Open accessThe DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Abstract
Metastatic cancer cells are lethal. Understanding the molecular mechanisms that bolster the conversion from benign to malignant progression is key for treating these heterogeneous and resistant neoplasms. The epithelial-mesenchymal transition (EMT) is a conserved cellular program that alters cell shape, adhesion and movement. The shift to a more mesenchymal-like phenotype can promote tumor cell intravasation of surrounding blood vessels and emigration to a new organ, yet may not be necessary for extravasation or colonization into that environment. Lymphatic dissemination, on the other hand, may not require EMT. This review presents emerging data on the modes by which tumor cells promote EMT/MET via microRNA and prepare the pre-metastatic niche via exosomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis
Valastyan, S., Benaich, N., Chang, A., Reinhardt, F., & Weinberg, R. A. (2009) · Genes & Development · doi:10.1101/gad.1832709 · Cited by 103
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 3×
“Some distinctions of Type III result from the abnormal expression of oncogenes and lack of tumor suppressor genes as a backdrop in the neoplastic cells, and the discord this causes subsequent to EMT activation (13).”
BackgroundMolecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 2×
“In TGFb-driven EMT, transcription factors, such as SMAD and BMP can initiate many of the EMT-related changes (12).”
BackgroundEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605 · cited 1×
“The well established EMT-promoting transcription factor, Twist, was also shown to increase miR10b expression (83).”
BackgroundEMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · cited 1×
“EMT also increases drug resistance and blocks immune surveillance – processes that promote metastasis (31,32).”
BackgroundRegulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 1×
“Evidence compiled from references within this review and other literatures (13,27,103).”
BackgroundPark, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
Ectosomes and exosomes: shedding the confusion between extracellular vesicles
Cocucci, E., & Meldolesi, J. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.01.004 · Cited by 1,435
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Epithelial–mesenchymal plasticity in carcinoma metastasis
Tsai, J. H., & Yang, J. (2013) · Genes & Development · doi:10.1101/gad.225334.113 · Cited by 1,136
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Functionally specialized junctions between endothelial cells of lymphatic vessels
Baluk, P., Fuxe, J., Hashizume, H., Romano, T., Lashnits, E., Butz, S., Vestweber, D., Corada, M., Molendini, C., Dejana, E., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062596 · Cited by 1,006
Ocaña, O. H., Córcoles, R., Fabra, Á., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., & Nieto, M. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.012 · Cited by 973
Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
Scheel, C., & Weinberg, R. A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.001 · Cited by 881
Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M. C., Tetta, C., Bussolati, B., & Camussi, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0241 · Cited by 851
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
Ansieau, S., Bastid, J., Doreau, A., Morel, A.-P., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.005 · Cited by 715
A MicroRNA Targeting Dicer for Metastasis Control
Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M., Spruce, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.017 · Cited by 667
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
López‐Novoa, J. M., & Nieto, M. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900043 · Cited by 654
Armstrong, A. J., Marengo, M. S., Oltean, S., Kemeny, G., Bitting, R. L., Turnbull, J. D., Herold, C. I., Marcom, P. K., George, D. J., & Garcia-Blanco, M. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0490 · Cited by 646
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., & Sahai, E. (2009) · Nature Cell Biology · doi:10.1038/ncb1973 · Cited by 601
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Boukouris, S., & Mathivanan, S. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400114 · Cited by 586
Gorges, T. M., Tinhofer, I., Drosch, M., Röse, L., Zollner, T. M., Krahn, T., & von Ahsen, O. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-178 · Cited by 565
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
EMT as the ultimate survival mechanism of cancer cells
Tiwari, N., Gheldof, A., Tatari, M., & Christofori, G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.013 · Cited by 512
EMT, CTCs and CSCs in tumor relapse and drug-resistance
Mitra, A., Mishra, L., & Li, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4037 · Cited by 465
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Celià-Terrassa, T., Meca-Cortés, Ó., Mateo, F., Martínez de Paz, A., Rubio, N., Arnal-Estapé, A., Ell, B. J., Bermudo, R., Díaz, A., Guerra-Rebollo, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59218 · Cited by 450
miR-200–containing extracellular vesicles promote breast cancer cell metastasis
Le, M. T. N., Hamar, P., Guo, C., Basar, E., Perdigão-Henriques, R., Balaj, L., & Lieberman, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75695 · Cited by 449
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
Webber, J. P., Spary, L. K., Sanders, A. J., Chowdhury, R., Jiang, W. G., Steadman, R., Wymant, J., Jones, A. T., Kynaston, H., Mason, M. D., et al. (2015) · Oncogene · doi:10.1038/onc.2013.560 · Cited by 438
Heterogeneity of the Tumor Vasculature
Nagy, J., Chang, S.-H., Shih, S.-C., Dvorak, A., & Dvorak, H. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1253454 · Cited by 422
miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis
Gebeshuber, C. A., Zatloukal, K., & Martinez, J. (2009) · EMBO reports · doi:10.1038/embor.2009.9 · Cited by 391
Ramteke, A., Ting, H., Agarwal, C., Mateen, S., Somasagara, R., Hussain, A., Graner, M., Frederick, B., Agarwal, R., & Deep, G. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22124 · Cited by 385
Lecharpentier, A., Vielh, P., Perez-Moreno, P., Planchard, D., Soria, J. C., & Farace, F. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.405 · Cited by 367
Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1392 · Cited by 361 · cited 1×
“For instance, overexpression of VEGF-C in cancer cells results in an increased volumetric flow rate in lymphatics, which increases the cancer cell accumulation in the sentinel node by 200-fold (62).”
BackgroundMultilayer control of the EMT master regulators
Zheng, H., & Kang, Y. (2014) · Oncogene · doi:10.1038/onc.2013.128 · Cited by 346
Aga, M., Bentz, G. L., Raffa, S., Torrisi, M. R., Kondo, S., Wakisaka, N., Yoshizaki, T., Pagano, J. S., & Shackelford, J. (2014) · Oncogene · doi:10.1038/onc.2014.66 · Cited by 337
The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells
Paňková, K., Rösel, D., Novotný, M., & Brábek, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0132-1 · Cited by 333
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
Dadras, S. S., Lange-Asschenfeldt, B., Velasco, P., Nguyen, L., Vora, A., Muzikansky, A., Jahnke, K., Hauschild, A., Hirakawa, S., Mihm, M. C., et al. (2005) · Modern Pathology · doi:10.1038/modpathol.3800410 · Cited by 326
The “seed and soil” hypothesis revisited
Fidler, I. J., & Poste, G. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70201-8 · Cited by 314
Nistico, P., Bissell, M. J., & Radisky, D. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011908 · Cited by 313
TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer
Stinson, S., Lackner, M. R., Adai, A. T., Yu, N., Kim, H.-J., O’Brien, C., Spoerke, J., Jhunjhunwala, S., Boyd, Z., Januario, T., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001538 · Cited by 303
Kumarswamy, R., Mudduluru, G., Ceppi, P., Muppala, S., Kozlowski, M., Niklinski, J., Papotti, M., & Allgayer, H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26218 · Cited by 298
The Regulatory Role of MicroRNAs in EMT and Cancer
Zaravinos, A. (2015) · Journal of Oncology · doi:10.1155/2015/865816 · Cited by 291
Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
Wu, S., Liu, S., Liu, Z., Huang, J., Pu, X., Li, J., Yang, D., Deng, H., Yang, N., & Xu, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123976 · Cited by 282
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?
Wong, S. Y., & Hynes, R. O. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2646 · Cited by 266
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
Lamouille, S., Subramanyam, D., Blelloch, R., & Derynck, R. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.008 · Cited by 259
EMT: A new vision of hypoxia promoting cancer progression
Jiang, J., Tang, Y.-L., & Liang, X.-H. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.8.15274 · Cited by 253
Han, M., Liu, M., Wang, Y., Chen, X., Xu, J., Sun, Y., Zhao, L., Qu, H., Fan, Y., & Wu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039520 · Cited by 247
Tsuji, T., Ibaragi, S., Shima, K., Hu, M. G., Katsurano, M., Sasaki, A., & Hu, G.-F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1444 · Cited by 236
Resolved: EMT Produces Fibroblasts in the Kidney
(2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060616 · Cited by 224
TGF β Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Papageorgis, P. (2015) · Journal of Oncology · doi:10.1155/2015/587193 · Cited by 223
Emerging roles of exosomes during epithelial–mesenchymal transition and cancer progression
Greening, D. W., Gopal, S. K., Mathias, R. A., Liu, L., Sheng, J., Zhu, H.-J., & Simpson, R. J. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.008 · Cited by 220
Twist: a molecular target in cancer therapeutics
Khan, M. A., Chen, H.-C., Zhang, D., & Fu, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1002-x · Cited by 209
Das, S., Sarrou, E., Podgrabinska, S., Cassella, M., Mungamuri, S. K., Feirt, N., Gordon, R., Nagi, C. S., Wang, Y., Entenberg, D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20111627 · Cited by 195
Moes, M., Le Béchec, A., Crespo, I., Laurini, C., Halavatyi, A., Vetter, G., del Sol, A., & Friederich, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035440 · Cited by 172
Tumor lymphangiogenesis and melanoma metastasis
Rinderknecht, M., & Detmar, M. J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21494 · Cited by 169
Wu, C., Tsai, Y., Wu, M.-Z., Teng, S., & Wu, K. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.05.005 · Cited by 163
Philip, B., Ito, K., Moreno-Sanchez, R., & Ralph, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt209 · Cited by 161
Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A., Gagliani, C., Tacchetti, C., Mauri, P., Melioli, G., & Pistoia, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075054 · Cited by 158
miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
Zhu, X., Shen, H., Yin, X., Long, L., Xie, C., Liu, Y., Hui, L., Lin, X., Fang, Y., Cao, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.84 · Cited by 157
Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis
Wang, Y., & Shang, Y. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.019 · Cited by 152
The EMT Universe: Space between Cancer Cell Dissemination and Metastasis Initiation
Ombrato, L., & Malanchi, I. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014011802 · Cited by 148
Yoshizaki, T., Kondo, S., Wakisaka, N., Murono, S., Endo, K., Sugimoto, H., Nakanishi, S., Tsuji, A., & Ito, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.018 · Cited by 143
Barrière, G., Fici, P., Gallerani, G., Fabbri, F., Zoli, W., & Rigaud, M. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.10.04 · Cited by 142
Samatov, T. R., Tonevitsky, A. G., & Schumacher, U. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-107 · Cited by 141
Warzecha, C. C., & Carstens, R. P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.003 · Cited by 137
Evaluation of microvascular density in tumors: pro and contra.
Nico, B., Benagiano, V., Mangieri, D., Maruotti, N., Vacca, A., & Ribatti, D. (2008) · PubMed · doi:10.14670/hh-23.601 · Cited by 133
Chui, M. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27745 · Cited by 132
The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
Vella, L. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00361 · Cited by 124
Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model
Banyard, J., Chung, I., Wilson, A. M., Vetter, G., Béchec, A. L., Bielenberg, D. R., & Zetter, B. R. (2013) · Scientific Reports · doi:10.1038/srep03151 · Cited by 76
Self-citationYan, Y., Wang, Q., Xiao-ling, Y. A. N., Zhang, Y., Li, W. S., Tang, F., Li, X., & Yang, P. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.005 · Cited by 63
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
Drasin, D. J., Guarnieri, A. L., Neelakantan, D., Kim, J., Cabrera, J. H., Wang, C.-A., Zaberezhnyy, V., Gasparini, P., Cascione, L., Huebner, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2394 · Cited by 59
Banyard, J., Chung, I., Migliozzi, M. T., Phan, D. T., Wilson, A. M., Zetter, B. R., & Bielenberg, D. R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-387 · Cited by 54
Self-citationTumor Plasticity Interferes with Anti-Tumor Immunity
Chouaib, S., Janji, B., Tittarelli, A., Eggermont, A., & Thiery, J. P. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010183 · Cited by 50
Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells
Nickel, A., & Stadler, S. C. (2014) · Translational research · doi:10.1016/j.trsl.2014.04.001 · Cited by 48
Xie, G., Ji, A., Yuan, Q., Jin, Z. X., Yuan, Y. S., Ren, C., Guo, Z., Qi, Y., Yang, K., Lin, X., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.153 · Cited by 47
A miR-590/Acvr2a/Rad51b Axis Regulates DNA Damage Repair during mESC Proliferation
Liu, Q., Wang, G., Chen, Y., Li, G., Yang, D., & Kang, J. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.10.006 · Cited by 37
D2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast
Lee, J. A., Bae, J. W., Woo, S. U., Kim, H., & Kim, C. H. (2011) · Journal of Breast Cancer · doi:10.4048/jbc.2011.14.2.104 · Cited by 28
Reversibility of the Snail-induced epithelial–mesenchymal transition revealed by the Cre–loxP system
Ozawa, M., & Kobayashi, W. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.012 · Cited by 15
Cited by
Cell adhesion in cancer: Beyond the migration of single cells
Janiszewska, M., Primi, M. C., & Izard, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007759 · Cited by 646
The role of lymphangiogenesis and angiogenesis in tumor metastasis
Paduch, R. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0281-9 · Cited by 315
Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Li, S., Pritchard, D. M., & Yu, L.-G. (2022) · Cancers · doi:10.3390/cancers14133263 · Cited by 82
Zhang, L., Yang, Y., Chai, L., Bu, H., Yang, Y., Huang, H., Ran, J., Zhu, Y., Li, L., Chen, F., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32530 · Cited by 29
“The EMT endows cancer cells with increased invasive and migratory capacity, thus enabling tumor dissemination and metastasis.(38) Tumor cells can acquire CSC-like properties through the EMT process, which is mediated by important transcription factors including Snail 1/2, Twist 1/2, E-cadherin and Vimentin.”
Background
Metadata
- Authors
- Banyard, J., & Bielenberg, D. R.
- Venue
- Connective Tissue Research
- Publisher
- Informa UK Limited
- Published
- 2015-08-20
- Volume
- 56
- Issue
- 5
- Pages
- 403-413
- ISSN
- 0300-8207 (ISSN-L)
- 1607-8438
- OpenAlex
- W1893005658
- Cited by
- 252
- References
- 97
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.